Slc2a1 | Rat | (-)-epigallocatechin 3-gallate | increases expression | EXP | | 6480464 | epigallocatechin gallate results in increased expression of SLC2A1 mRNA | CTD | PMID:16988119 |
Slc2a1 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC2A1 mRNA | CTD | PMID:22079256 |
Slc2a1 | Rat | (E)-cinnamyl alcohol | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [cinnamyl alcohol co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein | CTD | PMID:20955755 |
Slc2a1 | Rat | (E)-cinnamyl alcohol | increases activity | ISO | Slc2a1 (Mus musculus) | 6480464 | cinnamyl alcohol results in increased activity of SLC2A1 protein | CTD | PMID:20955755 |
Slc2a1 | Rat | (S)-naringenin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | naringenin inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
Slc2a1 | Rat | (S)-naringenin | decreases activity | ISO | SLC2A1 (Homo sapiens) | 6480464 | naringenin results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
Slc2a1 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of SLC2A1 mRNA | CTD | PMID:22206623 |
Slc2a1 | Rat | 1,4-benzoquinone | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [HIF1A protein co-treated with quinone] results in increased expression of SLC2A1 protein | CTD | PMID:30448556 |
Slc2a1 | Rat | 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine | multiple interactions | EXP | | 6480464 | Trimetazidine promotes the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA] | CTD | PMID:25937560 |
Slc2a1 | Rat | 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Trimetazidine results in decreased expression of SLC2A1 mRNA | CTD | PMID:37591408 |
Slc2a1 | Rat | 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile | increases expression | EXP | | 6480464 | Citalopram results in increased expression of SLC2A1 mRNA | CTD | PMID:28467792 |
Slc2a1 | Rat | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:25064079 |
Slc2a1 | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of SLC2A1 mRNA | CTD | PMID:17522070 |
Slc2a1 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of SLC2A1 mRNA | CTD | PMID:17555576 and PMID:17942748 |
Slc2a1 | Rat | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of SLC2A1 mRNA | CTD | PMID:12075121 more ... |
Slc2a1 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC2A1 mRNA | CTD | PMID:17942748 |
Slc2a1 | Rat | 17beta-estradiol | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Estradiol results in increased expression of SLC2A1 mRNA and Estradiol results in increased expression of SLC2A1 protein | CTD | PMID:14605097 and PMID:15350188 |
Slc2a1 | Rat | 17beta-estradiol | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Estradiol results in increased expression of SLC2A1 mRNA | CTD | PMID:39298647 |
Slc2a1 | Rat | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of SLC2A1 mRNA | CTD | PMID:32145629 |
Slc2a1 | Rat | 17beta-estradiol | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | Estradiol inhibits the reaction [Progesterone results in increased expression of and results in increased localization of SLC2A1 protein] and Estradiol inhibits the reaction [Progesterone results in increased expression of SLC2A1 protein] | CTD | PMID:18948400 |
Slc2a1 | Rat | 17beta-estradiol | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of SLC2A1 protein | CTD | PMID:15350188 |
Slc2a1 | Rat | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Dihydrotestosterone results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
Slc2a1 | Rat | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of SLC2A1 mRNA | CTD | PMID:29581250 |
Slc2a1 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [2 more ... | CTD | PMID:30821169 |
Slc2a1 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:30821169 |
Slc2a1 | Rat | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:30821169 and PMID:31251971 |
Slc2a1 | Rat | 2,3',4,4',5-Pentachlorobiphenyl | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [2 more ... | CTD | PMID:30821169 and PMID:31251971 |
Slc2a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC2A1 protein | CTD | PMID:17872374 |
Slc2a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC2A1 mRNA | CTD | PMID:34747641 |
Slc2a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC2A1 mRNA | CTD | PMID:19684285 more ... |
Slc2a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC2A1 mRNA | CTD | PMID:23152189 |
Slc2a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC2A1 mRNA | CTD | PMID:20959002 and PMID:33387578 |
Slc2a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC2A1 mRNA | CTD | PMID:17872374 and PMID:21570461 |
Slc2a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC2A1 mRNA | CTD | PMID:22298810 |
Slc2a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC2A1 mRNA | CTD | PMID:17035482 and PMID:19684285 |
Slc2a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC2A1 mRNA | CTD | PMID:17942748 |
Slc2a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC2A1 mRNA] more ... | CTD | PMID:19684285 and PMID:23152189 |
Slc2a1 | Rat | 2,3-dinitrophenol | increases activity | EXP | | 6480464 | 2 and 3-dinitrophenol results in increased activity of SLC2A1 protein | CTD | PMID:10970766 |
Slc2a1 | Rat | 2,3-dinitrophenol | multiple interactions | EXP | | 6480464 | Calcium deficiency inhibits the reaction [2 and 3-dinitrophenol results in increased activity of SLC2A1 protein] | CTD | PMID:10970766 |
Slc2a1 | Rat | 2,6-di-tert-butyl-4-methylphenol | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Butylated Hydroxytoluene results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
Slc2a1 | Rat | 2,6-dimethoxyphenol | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Sodium Chloride co-treated with pyrogallol 1 and 3-dimethyl ether] results in increased expression of and affects the localization of SLC2A1 protein | CTD | PMID:38598786 |
Slc2a1 | Rat | 2-deoxy-2-((18)F)fluoro-D-glucose | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [MRK 003 results in decreased expression of SLC2A1 protein] which results in decreased uptake of Fluorodeoxyglucose F18 | CTD | PMID:20197467 |
Slc2a1 | Rat | 2-deoxy-2-((18)F)fluoro-D-glucose | affects uptake | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 mRNA affects the uptake of Fluorodeoxyglucose F18 | CTD | PMID:16595493 |
Slc2a1 | Rat | 2-deoxy-D-glucose | increases uptake | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein results in increased uptake of Deoxyglucose | CTD | PMID:2173694 |
Slc2a1 | Rat | 2-deoxy-D-glucose | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [arsenite affects the localization of SLC2A1 protein] which results in increased uptake of Deoxyglucose | CTD | PMID:14511371 |
Slc2a1 | Rat | 2-deoxy-D-glucose | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Deoxyglucose results in increased abundance of Glucose] which affects the localization of SLC2A1 protein more ... | CTD | PMID:2173694 and PMID:31398423 |
Slc2a1 | Rat | 2-methoxy-17beta-estradiol | decreases expression | EXP | | 6480464 | 2-Methoxyestradiol results in decreased expression of SLC2A1 protein | CTD | PMID:31850806 and PMID:32461003 |
Slc2a1 | Rat | 2-methoxy-17beta-estradiol | multiple interactions | EXP | | 6480464 | 2-Methoxyestradiol promotes the reaction [methylmercuric chloride results in decreased expression of SLC2A1 protein] and 2-Methoxyestradiol promotes the reaction [Methylmercury Compounds results in decreased expression of SLC2A1 protein] | CTD | PMID:31850806 and PMID:32461003 |
Slc2a1 | Rat | 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [3 more ... | CTD | PMID:30821169 |
Slc2a1 | Rat | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:37080397 |
Slc2a1 | Rat | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | 3 more ... | CTD | PMID:30821169 and PMID:35618242 |
Slc2a1 | Rat | 3,3',5-triiodo-L-thyronine | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Triiodothyronine results in increased expression of SLC2A1 mRNA | CTD | PMID:15507505 |
Slc2a1 | Rat | 3,4-dihydroxybenzoic acid | increases expression | EXP | | 6480464 | protocatechuic acid results in increased expression of SLC2A1 protein | CTD | PMID:31850806 and PMID:32461003 |
Slc2a1 | Rat | 3,4-dihydroxybenzoic acid | multiple interactions | EXP | | 6480464 | protocatechuic acid inhibits the reaction [methylmercuric chloride results in decreased expression of SLC2A1 protein] and protocatechuic acid inhibits the reaction [Methylmercury Compounds results in decreased expression of SLC2A1 protein] | CTD | PMID:31850806 and PMID:32461003 |
Slc2a1 | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SLC2A1 mRNA | CTD | PMID:20188158 |
Slc2a1 | Rat | 3,5-diethoxycarbonyl-1,4-dihydrocollidine | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:20512997 |
Slc2a1 | Rat | 3-bromopyruvic acid | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [bromopyruvate results in decreased expression of SLC2A1 protein] which results in decreased uptake of Glucose | CTD | PMID:28433571 |
Slc2a1 | Rat | 3-bromopyruvic acid | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | bromopyruvate results in decreased expression of SLC2A1 mRNA and bromopyruvate results in decreased expression of SLC2A1 protein | CTD | PMID:28433571 |
Slc2a1 | Rat | 3-chloropropane-1,2-diol | decreases expression | EXP | | 6480464 | alpha-Chlorohydrin results in decreased expression of SLC2A1 mRNA | CTD | PMID:28522335 |
Slc2a1 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLC2A1 mRNA | CTD | PMID:31009676 |
Slc2a1 | Rat | 3-methyladenine | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | 3-methyladenine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A1 protein] more ... | CTD | PMID:32569804 more ... |
Slc2a1 | Rat | 3-methyladenine | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | 3-methyladenine results in decreased expression of SLC2A1 protein | CTD | PMID:36336208 |
Slc2a1 | Rat | 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of SLC2A1 mRNA | CTD | PMID:21800402 |
Slc2a1 | Rat | 3-O-methyl-D-glucose | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Pentobarbital inhibits the reaction [SLC2A1 protein results in increased uptake of 3-O-Methylglucose] more ... | CTD | PMID:10590023 |
Slc2a1 | Rat | 3-O-methyl-D-glucose | decreases transport | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein mutant form results in decreased transport of 3-O-Methylglucose | CTD | PMID:11603379 |
Slc2a1 | Rat | 3-O-methyl-D-glucose | increases uptake | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein results in increased uptake of 3-O-Methylglucose | CTD | PMID:10590023 |
Slc2a1 | Rat | 3-Phenyl-1-propanol | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [3-phenylpropanol-1 co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein | CTD | PMID:20955755 |
Slc2a1 | Rat | 3-Phenyl-1-propanol | increases activity | ISO | Slc2a1 (Mus musculus) | 6480464 | 3-phenylpropanol-1 results in increased activity of SLC2A1 protein | CTD | PMID:20955755 |
Slc2a1 | Rat | 3-phenylprop-2-enal | increases activity | ISO | Slc2a1 (Mus musculus) | 6480464 | cinnamaldehyde results in increased activity of SLC2A1 protein | CTD | PMID:20955755 |
Slc2a1 | Rat | 3-phenylprop-2-enal | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [cinnamaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein more ... | CTD | PMID:20955755 |
Slc2a1 | Rat | 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1 and 2-dithiol-3-thione results in decreased expression of SLC2A1 mRNA | CTD | PMID:19162173 |
Slc2a1 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | bisphenol S results in decreased expression of SLC2A1 mRNA | CTD | PMID:27685785 and PMID:35457000 |
Slc2a1 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Fenretinide results in increased expression of SLC2A1 mRNA | CTD | PMID:28973697 |
Slc2a1 | Rat | 4-phenylbutyric acid | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of SLC2A1 protein] | CTD | PMID:32569804 and PMID:36473502 |
Slc2a1 | Rat | 5-fluorouracil | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Fluorouracil results in decreased expression of SLC2A1 mRNA | CTD | PMID:16253763 |
Slc2a1 | Rat | 5-fluorouracil | decreases activity | ISO | SLC2A1 (Homo sapiens) | 6480464 | Fluorouracil results in decreased activity of SLC2A1 protein | CTD | PMID:16253763 |
Slc2a1 | Rat | 5-fluorouracil | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Fluorouracil results in increased expression of SLC2A1 mRNA | CTD | PMID:16595493 |
Slc2a1 | Rat | 7-hydroxyflavone | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | 7-hydroxyflavone inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
Slc2a1 | Rat | 7-hydroxyflavone | decreases activity | ISO | SLC2A1 (Homo sapiens) | 6480464 | 7-hydroxyflavone results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
Slc2a1 | Rat | acadesine | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | acadesine results in increased expression of SLC2A1 mRNA | CTD | PMID:15864539 |
Slc2a1 | Rat | acarbose | increases expression | EXP | | 6480464 | Acarbose results in increased expression of SLC2A1 protein | CTD | PMID:11779583 |
Slc2a1 | Rat | acrylamide | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Acrylamide results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
Slc2a1 | Rat | aflatoxin B1 | increases methylation | ISO | SLC2A1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of SLC2A1 intron | CTD | PMID:30157460 |
Slc2a1 | Rat | aflatoxin B1 | multiple interactions | EXP | | 6480464 | Sildenafil Citrate inhibits the reaction [Aflatoxin B1 results in increased expression of SLC2A1 mRNA] and Tadalafil inhibits the reaction [Aflatoxin B1 results in increased expression of SLC2A1 mRNA] | CTD | PMID:35608386 |
Slc2a1 | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of SLC2A1 mRNA | CTD | PMID:35608386 |
Slc2a1 | Rat | aldehydo-D-glucose | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [2-butenal co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein more ... | CTD | PMID:18948400 more ... |
Slc2a1 | Rat | aldehydo-D-glucose | increases uptake | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein results in increased uptake of Glucose | CTD | PMID:23615963 |
Slc2a1 | Rat | aldehydo-D-glucose | increases activity | ISO | Slc2a1 (Mus musculus) | 6480464 | Glucose deficiency results in increased activity of SLC2A1 protein | CTD | PMID:19686715 |
Slc2a1 | Rat | aldehydo-D-glucose | increases transport | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein results in increased transport of Glucose | CTD | PMID:18455367 and PMID:8457197 |
Slc2a1 | Rat | aldehydo-D-glucose | increases stability | ISO | SLC2A1 (Homo sapiens) | 6480464 | Glucose results in increased stability of SLC2A1 protein | CTD | PMID:11420438 |
Slc2a1 | Rat | aldehydo-D-glucose | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Glucose results in increased expression of SLC2A1 mRNA | CTD | PMID:15864539 |
Slc2a1 | Rat | aldehydo-D-glucose | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | 7-hydroxyflavone inhibits the reaction [SLC2A1 protein affects the transport of Glucose] more ... | CTD | PMID:14642735 more ... |
Slc2a1 | Rat | aldehydo-D-glucose | multiple interactions | EXP | | 6480464 | [troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose | CTD | PMID:10726906 |
Slc2a1 | Rat | aldehydo-D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of SLC2A1 mRNA | CTD | PMID:1727734 |
Slc2a1 | Rat | all-trans-retinoic acid | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Tretinoin results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
Slc2a1 | Rat | all-trans-retinoic acid | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of SLC2A1 mRNA | CTD | PMID:23724009 |
Slc2a1 | Rat | alpha,alpha-trehalose | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | Trehalose inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:25064079 |
Slc2a1 | Rat | alpha-naphthoflavone | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC2A1 mRNA] | CTD | PMID:23152189 |
Slc2a1 | Rat | alpha-naphthoflavone | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | alpha-naphthoflavone results in increased expression of SLC2A1 mRNA | CTD | PMID:23152189 |
Slc2a1 | Rat | aluminium atom | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Aluminum results in increased expression of SLC2A1 protein | CTD | PMID:16979867 |
Slc2a1 | Rat | aluminium(0) | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Aluminum results in increased expression of SLC2A1 protein | CTD | PMID:16979867 |
Slc2a1 | Rat | amiodarone | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Amiodarone results in decreased expression of SLC2A1 mRNA | CTD | PMID:36586010 |
Slc2a1 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SLC2A1 mRNA | CTD | PMID:16483693 |
Slc2a1 | Rat | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of SLC2A1 mRNA | CTD | PMID:30779732 |
Slc2a1 | Rat | anthracene-1,8,9-triol | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Anthralin results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
Slc2a1 | Rat | antirheumatic drug | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of SLC2A1 mRNA | CTD | PMID:24449571 |
Slc2a1 | Rat | Apaziquone | decreases response to substance | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein results in decreased susceptibility to apaziquone | CTD | PMID:17520257 |
Slc2a1 | Rat | apigenin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Apigenin inhibits the reaction [SLC2A1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1 and 3-diazol-4-yl)amino)-2-deoxyglucose] | CTD | PMID:36870413 |
Slc2a1 | Rat | apigenin | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Apigenin results in decreased expression of SLC2A1 mRNA and Apigenin results in decreased expression of SLC2A1 protein | CTD | PMID:37437745 |
Slc2a1 | Rat | aristolochic acid A | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of SLC2A1 mRNA | CTD | PMID:33212167 |
Slc2a1 | Rat | Aroclor 1254 | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC2A1 mRNA | CTD | PMID:23650126 |
Slc2a1 | Rat | arsane | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [[Deoxyglucose results in increased abundance of Glucose] which affects the localization of SLC2A1 protein] | CTD | PMID:31398423 |
Slc2a1 | Rat | arsenic atom | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [[Deoxyglucose results in increased abundance of Glucose] which affects the localization of SLC2A1 protein] | CTD | PMID:31398423 |
Slc2a1 | Rat | arsenic trichloride | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [arsenic trichloride co-treated with Ascorbic Acid] results in decreased expression of SLC2A1 mRNA | CTD | PMID:38160894 |
Slc2a1 | Rat | arsenite(3-) | affects localization | ISO | Slc2a1 (Mus musculus) | 6480464 | arsenite affects the localization of SLC2A1 protein | CTD | PMID:14511371 |
Slc2a1 | Rat | arsenite(3-) | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [arsenite affects the localization of SLC2A1 protein] which results in increased uptake of Deoxyglucose | CTD | PMID:14511371 |
Slc2a1 | Rat | arsenous acid | increases import | EXP | | 6480464 | SLC2A1 protein results in increased import of Arsenic Trioxide | CTD | PMID:17064664 |
Slc2a1 | Rat | arsenous acid | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Ascorbic Acid co-treated with Arsenic Trioxide] results in decreased expression of SLC2A1 protein more ... | CTD | PMID:35714947 and PMID:38160894 |
Slc2a1 | Rat | arsenous acid | affects localization | ISO | SLC2A1 (Homo sapiens) | 6480464 | Arsenic Trioxide affects the localization of SLC2A1 protein | CTD | PMID:35714947 |
Slc2a1 | Rat | arsenous acid | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of SLC2A1 mRNA and Arsenic Trioxide results in decreased expression of SLC2A1 protein | CTD | PMID:38160894 |
Slc2a1 | Rat | arsenous acid | increases import | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein results in increased import of Arsenic Trioxide | CTD | PMID:17064664 |
Slc2a1 | Rat | arsenous acid | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of SLC2A1 mRNA | CTD | PMID:20458559 and PMID:35714947 |
Slc2a1 | Rat | ATP | decreases stability | ISO | SLC2A1 (Homo sapiens) | 6480464 | Adenosine Triphosphate results in decreased stability of SLC2A1 protein | CTD | PMID:11420438 |
Slc2a1 | Rat | atrazine | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of SLC2A1 mRNA | CTD | PMID:22378314 |
Slc2a1 | Rat | Azaspiracid | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | azaspiracid results in increased expression of SLC2A1 mRNA | CTD | PMID:28939011 |
Slc2a1 | Rat | azide | multiple interactions | EXP | | 6480464 | Calcium deficiency inhibits the reaction [Azides results in increased activity of SLC2A1 protein] | CTD | PMID:10970766 |
Slc2a1 | Rat | azide | increases activity | EXP | | 6480464 | Azides results in increased activity of SLC2A1 protein | CTD | PMID:10970766 |
Slc2a1 | Rat | barbiturates | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Barbiturates inhibits the reaction [SLC2A1 protein results in increased transport of Glucose] | CTD | PMID:18455367 |
Slc2a1 | Rat | beauvericin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [beauvericin co-treated with enniatins] results in increased expression of SLC2A1 protein | CTD | PMID:32407736 |
Slc2a1 | Rat | benzaldehyde | increases activity | ISO | Slc2a1 (Mus musculus) | 6480464 | benzaldehyde results in increased activity of SLC2A1 protein | CTD | PMID:20955755 |
Slc2a1 | Rat | benzaldehyde | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [benzaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein | CTD | PMID:20955755 |
Slc2a1 | Rat | benzatropine | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Benztropine results in decreased expression of SLC2A1 protein | CTD | PMID:34122009 |
Slc2a1 | Rat | benzo[a]pyrene | affects expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the expression of SLC2A1 mRNA | CTD | PMID:20106945 |
Slc2a1 | Rat | benzo[a]pyrene | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of SLC2A1 mRNA | CTD | PMID:30453624 |
Slc2a1 | Rat | benzo[a]pyrene | affects methylation | ISO | SLC2A1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SLC2A1 3' UTR and Benzo(a)pyrene affects the methylation of SLC2A1 promoter | CTD | PMID:27901495 |
Slc2a1 | Rat | benzo[a]pyrene | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of SLC2A1 mRNA | CTD | PMID:21632981 |
Slc2a1 | Rat | benzo[a]pyrene | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of SLC2A1 mRNA | CTD | PMID:21569818 more ... |
Slc2a1 | Rat | benzo[a]pyrene diol epoxide I | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:26238291 |
Slc2a1 | Rat | beta-lapachone | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of SLC2A1 mRNA | CTD | PMID:38218311 |
Slc2a1 | Rat | beta-naphthoflavone | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC2A1 protein | CTD | PMID:28903497 |
Slc2a1 | Rat | beta-naphthoflavone | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in decreased expression of SLC2A1 mRNA | CTD | PMID:32858204 |
Slc2a1 | Rat | beta-naphthoflavone | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | beta-Naphthoflavone results in decreased expression of SLC2A1 mRNA | CTD | PMID:29521512 |
Slc2a1 | Rat | bicalutamide | multiple interactions | EXP | | 6480464 | bicalutamide promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of SLC2A1 protein] | CTD | PMID:35151640 |
Slc2a1 | Rat | bicalutamide | increases expression | EXP | | 6480464 | bicalutamide results in increased expression of SLC2A1 protein | CTD | PMID:35151640 |
Slc2a1 | Rat | bicalutamide | decreases expression | EXP | | 6480464 | bicalutamide results in decreased expression of SLC2A1 protein | CTD | PMID:35151640 |
Slc2a1 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
Slc2a1 | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A1 mRNA | CTD | PMID:37364641 |
Slc2a1 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of SLC2A1 mRNA | CTD | PMID:29753845 more ... |
Slc2a1 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of SLC2A1 protein | CTD | PMID:31163220 |
Slc2a1 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in increased expression of SLC2A1 mRNA | CTD | PMID:31163220 |
Slc2a1 | Rat | bisphenol A | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of SLC2A1 mRNA and bisphenol A results in increased expression of SLC2A1 protein | CTD | PMID:24349194 more ... |
Slc2a1 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLC2A1 protein | CTD | PMID:36291063 |
Slc2a1 | Rat | bisphenol A | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [bisphenol A results in increased activity of and affects the localization of SLC2A1 protein] which results in increased uptake of Glucose and bisphenol A results in increased activity of and affects the localization of SLC2A1 protein | CTD | PMID:32403449 |
Slc2a1 | Rat | bisphenol A | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A1 mRNA | CTD | PMID:37364641 |
Slc2a1 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of SLC2A1 mRNA | CTD | PMID:32145629 |
Slc2a1 | Rat | bisphenol A | affects expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | bisphenol A affects the expression of SLC2A1 and bisphenol A affects the expression of SLC2A1 mRNA | CTD | PMID:30903817 and PMID:34205666 |
Slc2a1 | Rat | bisphenol A | decreases methylation | ISO | Slc2a1 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of SLC2A1 promoter | CTD | PMID:27312807 |
Slc2a1 | Rat | bisphenol A | increases methylation | ISO | Slc2a1 (Mus musculus) | 6480464 | bisphenol A results in increased methylation of SLC2A1 promoter | CTD | PMID:27312807 |
Slc2a1 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SLC2A1 mRNA and bisphenol A results in increased expression of SLC2A1 protein | CTD | PMID:12075121 more ... |
Slc2a1 | Rat | bisphenol A | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of SLC2A1 mRNA and bisphenol A results in decreased expression of SLC2A1 protein | CTD | PMID:25637671 more ... |
Slc2a1 | Rat | bisphenol F | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | bisphenol F results in increased expression of SLC2A1 mRNA and bisphenol F results in increased expression of SLC2A1 protein | CTD | PMID:34147605 |
Slc2a1 | Rat | bisphenol F | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol F results in increased expression of SLC2A1 mRNA] more ... | CTD | PMID:34147605 |
Slc2a1 | Rat | bromobenzene | increases expression | EXP | | 6480464 | bromobenzene results in increased expression of SLC2A1 mRNA | CTD | PMID:32479839 |
Slc2a1 | Rat | bruceine D | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | bruceine D results in decreased expression of SLC2A1 protein | CTD | PMID:34900531 |
Slc2a1 | Rat | bruceine D | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | bruceine D affects the reaction [Oxygen deficiency affects the expression of SLC2A1 protein] and CTNNBIP1 protein affects the reaction [bruceine D affects the reaction [Oxygen deficiency affects the expression of SLC2A1 protein]] | CTD | PMID:34900531 |
Slc2a1 | Rat | bucladesine | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Progesterone co-treated with Bucladesine] results in increased expression of SLC2A1 protein | CTD | PMID:18948400 |
Slc2a1 | Rat | bupivacaine | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Bupivacaine results in decreased expression of SLC2A1 protein | CTD | PMID:34793778 |
Slc2a1 | Rat | bupivacaine | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of SLC2A1 protein] | CTD | PMID:34793778 |
Slc2a1 | Rat | butan-1-ol | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | 1-Butanol inhibits the reaction [Phospholipids results in increased localization of SLC2A1 protein] | CTD | PMID:15956784 |
Slc2a1 | Rat | butylated hydroxyanisole | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Butylated Hydroxyanisole results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
Slc2a1 | Rat | Butylbenzyl phthalate | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A1 mRNA | CTD | PMID:37364641 |
Slc2a1 | Rat | butyric acid | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA] | CTD | PMID:29751049 |
Slc2a1 | Rat | butyric acid | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | SIRT4 protein affects the reaction [Butyric Acid results in decreased expression of SLC2A1 mRNA] and SIRT4 protein affects the reaction [Butyric Acid results in decreased expression of SLC2A1 protein] | CTD | PMID:39241941 |
Slc2a1 | Rat | butyric acid | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Butyric Acid results in decreased expression of SLC2A1 mRNA and Butyric Acid results in decreased expression of SLC2A1 protein | CTD | PMID:39241941 |
Slc2a1 | Rat | cadmium acetate | multiple interactions | EXP | | 6480464 | [cadmium acetate results in increased abundance of Cadmium] which results in decreased expression of SLC2A1 protein and puerarin inhibits the reaction [[cadmium acetate results in increased abundance of Cadmium] which results in decreased expression of SLC2A1 protein] | CTD | PMID:33404196 |
Slc2a1 | Rat | cadmium atom | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Cadmium results in increased expression of SLC2A1 mRNA | CTD | PMID:22562489 |
Slc2a1 | Rat | cadmium atom | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | 3-methyladenine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A1 protein] more ... | CTD | PMID:34481905 and PMID:36336208 |
Slc2a1 | Rat | cadmium atom | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC2A1 mRNA and [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A1 protein | CTD | PMID:29373603 and PMID:34481905 |
Slc2a1 | Rat | cadmium atom | multiple interactions | EXP | | 6480464 | [cadmium acetate results in increased abundance of Cadmium] which results in decreased expression of SLC2A1 protein and puerarin inhibits the reaction [[cadmium acetate results in increased abundance of Cadmium] which results in decreased expression of SLC2A1 protein] | CTD | PMID:33404196 |
Slc2a1 | Rat | cadmium dichloride | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of SLC2A1 mRNA | CTD | PMID:12760830 |
Slc2a1 | Rat | cadmium dichloride | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Cadmium Chloride results in decreased expression of SLC2A1 protein | CTD | PMID:37487938 |
Slc2a1 | Rat | cadmium dichloride | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | 3-methyladenine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A1 protein] more ... | CTD | PMID:34481905 and PMID:36336208 |
Slc2a1 | Rat | cadmium dichloride | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:30615929 |
Slc2a1 | Rat | cadmium dichloride | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:12160620 and PMID:25596134 |
Slc2a1 | Rat | cadmium dichloride | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC2A1 mRNA more ... | CTD | PMID:23880315 more ... |
Slc2a1 | Rat | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:19010381 |
Slc2a1 | Rat | caffeine | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Caffeine results in increased expression of SLC2A1 protein | CTD | PMID:25486098 |
Slc2a1 | Rat | caffeine | decreases phosphorylation | ISO | SLC2A1 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of SLC2A1 protein | CTD | PMID:35688186 |
Slc2a1 | Rat | calcitriol | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of SLC2A1 mRNA and Calcitriol results in decreased expression of SLC2A1 protein | CTD | PMID:37792677 |
Slc2a1 | Rat | calcium atom | multiple interactions | EXP | | 6480464 | Calcium deficiency inhibits the reaction [2 more ... | CTD | PMID:10970766 |
Slc2a1 | Rat | calcium(0) | multiple interactions | EXP | | 6480464 | Calcium deficiency inhibits the reaction [2 more ... | CTD | PMID:10970766 |
Slc2a1 | Rat | cannabidiol | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Cannabidiol results in decreased expression of SLC2A1 protein | CTD | PMID:34122009 |
Slc2a1 | Rat | carbon nanotube | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 |
Slc2a1 | Rat | CCCP | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A1 protein] | CTD | PMID:34481905 |
Slc2a1 | Rat | celecoxib | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | Celecoxib inhibits the reaction [Nickel results in increased expression of SLC2A1 mRNA] | CTD | PMID:27452194 |
Slc2a1 | Rat | celecoxib | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Celecoxib results in increased expression of SLC2A1 mRNA | CTD | PMID:19327236 |
Slc2a1 | Rat | chloral hydrate | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Chloral Hydrate inhibits the reaction [SLC2A1 protein results in increased transport of Glucose] | CTD | PMID:18455367 |
Slc2a1 | Rat | chloroacetaldehyde | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | chloroacetaldehyde results in increased expression of SLC2A1 mRNA | CTD | PMID:25596134 |
Slc2a1 | Rat | chloroform | increases expression | EXP | | 6480464 | Chloroform results in increased expression of SLC2A1 mRNA | CTD | PMID:17522070 |
Slc2a1 | Rat | chloropicrin | affects expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | chloropicrin affects the expression of SLC2A1 mRNA | CTD | PMID:26352163 |
Slc2a1 | Rat | chloropicrin | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | chloropicrin results in decreased expression of SLC2A1 mRNA | CTD | PMID:28476498 |
Slc2a1 | Rat | chloroprene | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Chloroprene results in increased expression of SLC2A1 mRNA | CTD | PMID:23125180 |
Slc2a1 | Rat | chlorpyrifos | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of SLC2A1 mRNA | CTD | PMID:37019170 |
Slc2a1 | Rat | cholic acid | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Cholic Acid results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
Slc2a1 | Rat | chromium atom | multiple interactions | EXP | | 6480464 | Chromium inhibits the reaction [Dietary Fats results in decreased expression of SLC2A1 protein] | CTD | PMID:21120707 |
Slc2a1 | Rat | chromium(6+) | affects expression | ISO | Slc2a1 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of SLC2A1 mRNA | CTD | PMID:28472532 |
Slc2a1 | Rat | chromium(6+) | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | MPC1 protein inhibits the reaction [chromium hexavalent ion results in increased expression of SLC2A1 protein] | CTD | PMID:38992767 |
Slc2a1 | Rat | chromium(6+) | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | chromium hexavalent ion results in increased expression of SLC2A1 mRNA and chromium hexavalent ion results in increased expression of SLC2A1 protein | CTD | PMID:30690063 and PMID:38992767 |
Slc2a1 | Rat | cidofovir anhydrous | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Cidofovir results in increased expression of SLC2A1 mRNA | CTD | PMID:25596134 |
Slc2a1 | Rat | cinnamyl alcohol | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [cinnamyl alcohol co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein | CTD | PMID:20955755 |
Slc2a1 | Rat | cinnamyl alcohol | increases activity | ISO | Slc2a1 (Mus musculus) | 6480464 | cinnamyl alcohol results in increased activity of SLC2A1 protein | CTD | PMID:20955755 |
Slc2a1 | Rat | ciprofloxacin | affects localization | ISO | SLC2A1 (Homo sapiens) | 6480464 | Ciprofloxacin affects the localization of SLC2A1 mRNA | CTD | PMID:19022360 |
Slc2a1 | Rat | ciprofloxacin | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Ciprofloxacin results in decreased expression of SLC2A1 mRNA | CTD | PMID:19022360 |
Slc2a1 | Rat | cisplatin | increases phosphorylation | ISO | Slc2a1 (Mus musculus) | 6480464 | Cisplatin results in increased phosphorylation of SLC2A1 protein | CTD | PMID:22006019 |
Slc2a1 | Rat | cisplatin | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of SLC2A1 mRNA | CTD | PMID:29690507 |
Slc2a1 | Rat | cisplatin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Cisplatin co-treated with eprenetapopt] promotes the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA] more ... | CTD | PMID:27392435 and PMID:29690507 |
Slc2a1 | Rat | cisplatin | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of SLC2A1 mRNA | CTD | PMID:25596134 |
Slc2a1 | Rat | citalopram | increases expression | EXP | | 6480464 | Citalopram results in increased expression of SLC2A1 mRNA | CTD | PMID:28467792 |
Slc2a1 | Rat | clobetasol | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Clobetasol results in increased expression of SLC2A1 mRNA | CTD | PMID:27462272 |
Slc2a1 | Rat | clofibrate | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Clofibrate results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
Slc2a1 | Rat | cobalt dichloride | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [cobaltous chloride results in increased expression of SLC2A1 protein] more ... | CTD | PMID:17442736 more ... |
Slc2a1 | Rat | cobalt dichloride | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of SLC2A1 mRNA and cobaltous chloride results in increased expression of SLC2A1 protein | CTD | PMID:12032628 more ... |
Slc2a1 | Rat | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of SLC2A1 mRNA and cobaltous chloride results in increased expression of SLC2A1 protein | CTD | PMID:12819242 more ... |
Slc2a1 | Rat | cobalt dichloride | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | cobaltous chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:11043581 and PMID:24265542 |
Slc2a1 | Rat | cobalt dichloride | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with cobaltous chloride] results in increased expression of SLC2A1 mRNA more ... | CTD | PMID:18331222 more ... |
Slc2a1 | Rat | cobalt dichloride | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | ARNT affects the reaction [cobaltous chloride results in increased expression of SLC2A1 mRNA] | CTD | PMID:11043581 |
Slc2a1 | Rat | colforsin daropate hydrochloride | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Colforsin results in increased expression of SLC2A1 protein | CTD | PMID:38296531 |
Slc2a1 | Rat | colforsin daropate hydrochloride | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | cobaltous chloride inhibits the reaction [Valproic Acid inhibits the reaction [Colforsin results in increased expression of SLC2A1 protein]] and Valproic Acid inhibits the reaction [Colforsin results in increased expression of SLC2A1 protein] | CTD | PMID:38296531 |
Slc2a1 | Rat | copper atom | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of SLC2A1 mRNA more ... | CTD | PMID:20971185 more ... |
Slc2a1 | Rat | copper(0) | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of SLC2A1 mRNA more ... | CTD | PMID:20971185 more ... |
Slc2a1 | Rat | copper(II) chloride | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | cupric chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:15741220 |
Slc2a1 | Rat | copper(II) sulfate | affects expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Copper Sulfate affects the expression of SLC2A1 mRNA | CTD | PMID:19549813 |
Slc2a1 | Rat | cordycepin | multiple interactions | EXP | | 6480464 | cordycepin inhibits the reaction [Hydrogen Peroxide results in decreased expression of SLC2A1 mRNA] and cordycepin inhibits the reaction [Hydrogen Peroxide results in decreased expression of SLC2A1 protein] | CTD | PMID:35196519 |
Slc2a1 | Rat | cordycepin | increases expression | EXP | | 6480464 | cordycepin results in increased expression of SLC2A1 mRNA and cordycepin results in increased expression of SLC2A1 protein | CTD | PMID:35196519 |
Slc2a1 | Rat | corosolic acid | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of SLC2A1 mRNA] | CTD | PMID:34296331 |
Slc2a1 | Rat | corticosterone | increases expression | EXP | | 6480464 | Corticosterone results in increased expression of SLC2A1 mRNA | CTD | PMID:15755911 |
Slc2a1 | Rat | corticosterone | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA more ... | CTD | PMID:29751049 |
Slc2a1 | Rat | crotonaldehyde | increases activity | ISO | Slc2a1 (Mus musculus) | 6480464 | 2-butenal results in increased activity of SLC2A1 protein | CTD | PMID:20955755 |
Slc2a1 | Rat | crotonaldehyde | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [2-butenal co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein | CTD | PMID:20955755 |
Slc2a1 | Rat | cumene | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [cumene co-treated with KRAS gene mutant form] results in decreased expression of SLC2A1 mRNA | CTD | PMID:18648096 |
Slc2a1 | Rat | curcumin | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Curcumin results in decreased expression of SLC2A1 mRNA | CTD | PMID:21397623 |
Slc2a1 | Rat | curcumin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | ATF4 inhibits the reaction [Curcumin results in decreased expression of SLC2A1 protein] more ... | CTD | PMID:36640941 |
Slc2a1 | Rat | curcumin | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Curcumin results in decreased expression of SLC2A1 protein | CTD | PMID:36640941 |
Slc2a1 | Rat | Cyclofenil | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Cyclofenil inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
Slc2a1 | Rat | Cyclofenil | decreases activity | ISO | SLC2A1 (Homo sapiens) | 6480464 | Cyclofenil results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
Slc2a1 | Rat | cycloheximide | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of SLC2A1 mRNA | CTD | PMID:19684285 |
Slc2a1 | Rat | cyclosporin A | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Cyclosporine results in increased expression of SLC2A1 mRNA | CTD | PMID:19770486 |
Slc2a1 | Rat | cyclosporin A | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of SLC2A1 mRNA | CTD | PMID:25596134 |
Slc2a1 | Rat | cyclosporin A | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of SLC2A1 mRNA | CTD | PMID:25562108 |
Slc2a1 | Rat | cytarabine | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Cytarabine results in decreased expression of SLC2A1 mRNA | CTD | PMID:21198554 |
Slc2a1 | Rat | cytochalasin B | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | oxophenylarsine inhibits the reaction [Cytochalasin B binds to SLC2A1 protein] | CTD | PMID:19686715 |
Slc2a1 | Rat | cytochalasin B | affects binding | ISO | Slc2a1 (Mus musculus) | 6480464 | Cytochalasin B binds to SLC2A1 protein | CTD | PMID:19686715 |
Slc2a1 | Rat | cytochalasin B | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Cytochalasin B binds to and results in decreased activity of SLC2A1 protein and Cytochalasin B inhibits the reaction [SLC2A1 protein results in increased transport of Glucose] | CTD | PMID:27078104 and PMID:8457197 |
Slc2a1 | Rat | cytochalasin B | affects folding | ISO | SLC2A1 (Homo sapiens) | 6480464 | Cytochalasin B affects the folding of SLC2A1 protein | CTD | PMID:22363641 |
Slc2a1 | Rat | D-glucose | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | 7-hydroxyflavone inhibits the reaction [SLC2A1 protein affects the transport of Glucose] more ... | CTD | PMID:14642735 more ... |
Slc2a1 | Rat | D-glucose | increases uptake | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein results in increased uptake of Glucose | CTD | PMID:23615963 |
Slc2a1 | Rat | D-glucose | multiple interactions | EXP | | 6480464 | [troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose | CTD | PMID:10726906 |
Slc2a1 | Rat | D-glucose | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Glucose results in increased expression of SLC2A1 mRNA | CTD | PMID:15864539 |
Slc2a1 | Rat | D-glucose | increases activity | ISO | Slc2a1 (Mus musculus) | 6480464 | Glucose deficiency results in increased activity of SLC2A1 protein | CTD | PMID:19686715 |
Slc2a1 | Rat | D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of SLC2A1 mRNA | CTD | PMID:1727734 |
Slc2a1 | Rat | D-glucose | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [2-butenal co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein more ... | CTD | PMID:18948400 more ... |
Slc2a1 | Rat | D-glucose | increases transport | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein results in increased transport of Glucose | CTD | PMID:18455367 and PMID:8457197 |
Slc2a1 | Rat | D-glucose | increases stability | ISO | SLC2A1 (Homo sapiens) | 6480464 | Glucose results in increased stability of SLC2A1 protein | CTD | PMID:11420438 |
Slc2a1 | Rat | dacarbazine | decreases response to substance | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein results in decreased susceptibility to Dacarbazine | CTD | PMID:17520257 |
Slc2a1 | Rat | daidzein | decreases activity | ISO | SLC2A1 (Homo sapiens) | 6480464 | daidzein results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
Slc2a1 | Rat | daidzein | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | daidzein inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
Slc2a1 | Rat | DDE | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC2A1 mRNA | CTD | PMID:38568856 |
Slc2a1 | Rat | DDE | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC2A1 mRNA | CTD | PMID:36674557 |
Slc2a1 | Rat | DDT | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [DDT results in increased expression of SLC2A1 mRNA] more ... | CTD | PMID:31724279 |
Slc2a1 | Rat | DDT | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | DDT results in increased expression of SLC2A1 mRNA | CTD | PMID:31724279 |
Slc2a1 | Rat | deguelin | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | deguelin results in increased expression of SLC2A1 mRNA | CTD | PMID:33512557 |
Slc2a1 | Rat | Deoxycorticosterone acetate | multiple interactions | EXP | | 6480464 | [Desoxycorticosterone Acetate co-treated with Sodium Chloride co-treated with cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester] results in increased expression of SLC2A1 protein | CTD | PMID:29621749 |
Slc2a1 | Rat | desferrioxamine B | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Deferoxamine results in decreased abundance of Oxygen] which results in increased expression of SLC2A1 protein more ... | CTD | PMID:17442736 and PMID:36116563 |
Slc2a1 | Rat | desferrioxamine B | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Deferoxamine results in increased expression of SLC2A1 mRNA | CTD | PMID:12032628 and PMID:21558026 |
Slc2a1 | Rat | dexamethasone | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLC2A1 mRNA and Dexamethasone inhibits the reaction [Nickel results in increased expression of SLC2A1 mRNA] | CTD | PMID:27452194 and PMID:31009676 |
Slc2a1 | Rat | dextran sulfate | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Dextran Sulfate results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
Slc2a1 | Rat | Di-n-octyl phthalate | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A1 mRNA | CTD | PMID:37364641 |
Slc2a1 | Rat | diallyl trisulfide | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | diallyl trisulfide results in decreased expression of SLC2A1 mRNA | CTD | PMID:34995734 |
Slc2a1 | Rat | diarsenic trioxide | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of SLC2A1 mRNA | CTD | PMID:20458559 and PMID:35714947 |
Slc2a1 | Rat | diarsenic trioxide | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Ascorbic Acid co-treated with Arsenic Trioxide] results in decreased expression of SLC2A1 protein more ... | CTD | PMID:35714947 and PMID:38160894 |
Slc2a1 | Rat | diarsenic trioxide | affects localization | ISO | SLC2A1 (Homo sapiens) | 6480464 | Arsenic Trioxide affects the localization of SLC2A1 protein | CTD | PMID:35714947 |
Slc2a1 | Rat | diarsenic trioxide | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of SLC2A1 mRNA and Arsenic Trioxide results in decreased expression of SLC2A1 protein | CTD | PMID:38160894 |
Slc2a1 | Rat | diarsenic trioxide | increases import | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein results in increased import of Arsenic Trioxide | CTD | PMID:17064664 |
Slc2a1 | Rat | diarsenic trioxide | increases import | EXP | | 6480464 | SLC2A1 protein results in increased import of Arsenic Trioxide | CTD | PMID:17064664 |
Slc2a1 | Rat | diazepam | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Diazepam inhibits the reaction [SLC2A1 protein results in increased transport of Glucose] | CTD | PMID:18455367 |
Slc2a1 | Rat | dibenz[a,h]anthracene | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:16269432 |
Slc2a1 | Rat | Dibutyl phosphate | affects expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of SLC2A1 mRNA | CTD | PMID:37042841 |
Slc2a1 | Rat | dibutyl phthalate | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A1 mRNA | CTD | PMID:37364641 |
Slc2a1 | Rat | dichloroacetic acid | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Dichloroacetic Acid results in decreased expression of SLC2A1 mRNA and Dichloroacetic Acid results in decreased expression of SLC2A1 protein | CTD | PMID:22705712 |
Slc2a1 | Rat | dicrotophos | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of SLC2A1 mRNA | CTD | PMID:28302478 |
Slc2a1 | Rat | diethyl phthalate | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A1 mRNA | CTD | PMID:37364641 |
Slc2a1 | Rat | diethylstilbestrol | decreases activity | ISO | SLC2A1 (Homo sapiens) | 6480464 | Diethylstilbestrol results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
Slc2a1 | Rat | diethylstilbestrol | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Diethylstilbestrol inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
Slc2a1 | Rat | Dihydrotanshinone I | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | dihydrotanshinone I inhibits the reaction [Oxygen deficiency results in increased expression of SLC2A1 protein] | CTD | PMID:26282490 |
Slc2a1 | Rat | Diisodecyl phthalate | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A1 mRNA | CTD | PMID:37364641 |
Slc2a1 | Rat | diisononyl phthalate | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | diisononyl phthalate results in decreased expression of SLC2A1 mRNA | CTD | PMID:37482143 |
Slc2a1 | Rat | diisononyl phthalate | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of SLC2A1 mRNA | CTD | PMID:37364641 |
Slc2a1 | Rat | dinophysistoxin 1 | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | dinophysistoxin 1 results in increased expression of SLC2A1 mRNA | CTD | PMID:28939011 |
Slc2a1 | Rat | dioxygen | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of SLC2A1 protein] more ... | CTD | PMID:10780954 more ... |
Slc2a1 | Rat | dioxygen | affects expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Oxygen deficiency affects the expression of SLC2A1 protein | CTD | PMID:34900531 |
Slc2a1 | Rat | dioxygen | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of SLC2A1 mRNA and Oxygen deficiency results in increased expression of SLC2A1 protein | CTD | PMID:10780954 more ... |
Slc2a1 | Rat | dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of SLC2A1 mRNA and Oxygen deficiency results in increased expression of SLC2A1 protein | CTD | PMID:11524615 more ... |
Slc2a1 | Rat | dioxygen | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Oxygen results in decreased expression of SLC2A1 mRNA | CTD | PMID:23034257 |
Slc2a1 | Rat | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of SLC2A1 mRNA more ... | CTD | PMID:18331222 more ... |
Slc2a1 | Rat | dioxygen | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC2A1 mRNA more ... | CTD | PMID:20412331 more ... |
Slc2a1 | Rat | dioxygen | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of SLC2A1 mRNA | CTD | PMID:20412331 more ... |
Slc2a1 | Rat | dioxygen | decreases response to substance | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein results in decreased susceptibility to Oxygen deficiency | CTD | PMID:10780954 |
Slc2a1 | Rat | dorsomorphin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:34053323 |
Slc2a1 | Rat | doxorubicin | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of SLC2A1 mRNA | CTD | PMID:16595493 and PMID:29803840 |
Slc2a1 | Rat | doxorubicin | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Doxorubicin results in decreased expression of SLC2A1 mRNA | CTD | PMID:34296331 |
Slc2a1 | Rat | doxorubicin | multiple interactions | EXP | | 6480464 | KLF5 protein affects the reaction [Doxorubicin affects the expression of SLC2A1 protein] more ... | CTD | PMID:36805482 |
Slc2a1 | Rat | doxorubicin | affects expression | EXP | | 6480464 | Doxorubicin affects the expression of SLC2A1 protein | CTD | PMID:36805482 |
Slc2a1 | Rat | doxorubicin | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of SLC2A1 mRNA | CTD | PMID:22908232 |
Slc2a1 | Rat | doxorubicin | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of SLC2A1 mRNA and corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of SLC2A1 mRNA] | CTD | PMID:21040762 and PMID:34296331 |
Slc2a1 | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of SLC2A1 mRNA | CTD | PMID:29391264 |
Slc2a1 | Rat | enniatin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [beauvericin co-treated with enniatins] results in increased expression of SLC2A1 protein | CTD | PMID:32407736 |
Slc2a1 | Rat | epoxiconazole | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of SLC2A1 mRNA | CTD | PMID:35436446 |
Slc2a1 | Rat | escitalopram | increases expression | EXP | | 6480464 | Escitalopram results in increased expression of SLC2A1 mRNA | CTD | PMID:28467792 |
Slc2a1 | Rat | ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of SLC2A1 mRNA | CTD | PMID:17920746 |
Slc2a1 | Rat | ethanol | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [lard co-treated with Ethanol co-treated with High Fructose Corn Syrup] results in decreased expression of SLC2A14 protein and m-trifluoromethyl-diphenyl diselenide inhibits the reaction [[lard co-treated with Ethanol co-treated with High Fructose Corn Syrup] results in decreased expression of SLC2A14 protein] | CTD | PMID:37023972 |
Slc2a1 | Rat | ethanol | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Ethanol co-treated with Folic Acid] results in increased expression of SLC2A1 mRNA | CTD | PMID:23378141 |
Slc2a1 | Rat | ethanol | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Ethanol results in increased expression of SLC2A1 mRNA | CTD | PMID:19167417 and PMID:30319688 |
Slc2a1 | Rat | ethyl methanesulfonate | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of SLC2A1 mRNA | CTD | PMID:23649840 |
Slc2a1 | Rat | eupatilin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | eupatilin inhibits the reaction [SLC2A1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1 and 3-diazol-4-yl)amino)-2-deoxyglucose] | CTD | PMID:36870413 |
Slc2a1 | Rat | fenbendazole | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Fenbendazole analog results in decreased expression of SLC2A1 mRNA and Fenbendazole results in decreased expression of SLC2A1 mRNA | CTD | PMID:35569513 |
Slc2a1 | Rat | fenthion | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Fenthion results in decreased expression of SLC2A1 mRNA | CTD | PMID:34813904 |
Slc2a1 | Rat | folic acid | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Ethanol co-treated with Folic Acid] results in increased expression of SLC2A1 mRNA | CTD | PMID:23378141 |
Slc2a1 | Rat | formaldehyde | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Deferoxamine inhibits the reaction [myricetin inhibits the reaction [Formaldehyde results in increased expression of SLC2A1 mRNA]] more ... | CTD | PMID:36116563 |
Slc2a1 | Rat | formaldehyde | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | 2-amino-3-(4'-N more ... | CTD | PMID:37105513 |
Slc2a1 | Rat | formaldehyde | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of SLC2A1 mRNA and Formaldehyde results in increased expression of SLC2A1 protein | CTD | PMID:36116563 |
Slc2a1 | Rat | fulvestrant | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | Fulvestrant inhibits the reaction [bisphenol F results in increased expression of SLC2A1 protein] | CTD | PMID:34147605 |
Slc2a1 | Rat | furfural | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of SLC2A1 protein | CTD | PMID:38598786 |
Slc2a1 | Rat | Fusaric acid | affects expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Fusaric Acid affects the expression of SLC2A1 mRNA | CTD | PMID:32156565 |
Slc2a1 | Rat | Genipin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | genipin inhibits the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA] | CTD | PMID:29630948 |
Slc2a1 | Rat | genistein | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Genistein inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
Slc2a1 | Rat | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of SLC2A1 mRNA | CTD | PMID:12075121 |
Slc2a1 | Rat | genistein | decreases activity | ISO | SLC2A1 (Homo sapiens) | 6480464 | Genistein results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
Slc2a1 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of SLC2A1 mRNA | CTD | PMID:33387578 |
Slc2a1 | Rat | gentamycin C | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | gentamicin C results in increased expression of SLC2A1 mRNA | CTD | PMID:12927799 |
Slc2a1 | Rat | glucose | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | 7-hydroxyflavone inhibits the reaction [SLC2A1 protein affects the transport of Glucose] more ... | CTD | PMID:14642735 more ... |
Slc2a1 | Rat | glucose | increases uptake | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein results in increased uptake of Glucose | CTD | PMID:23615963 |
Slc2a1 | Rat | glucose | multiple interactions | EXP | | 6480464 | [troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose | CTD | PMID:10726906 |
Slc2a1 | Rat | glucose | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Glucose results in increased expression of SLC2A1 mRNA | CTD | PMID:15864539 |
Slc2a1 | Rat | glucose | increases activity | ISO | Slc2a1 (Mus musculus) | 6480464 | Glucose deficiency results in increased activity of SLC2A1 protein | CTD | PMID:19686715 |
Slc2a1 | Rat | glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of SLC2A1 mRNA | CTD | PMID:1727734 |
Slc2a1 | Rat | glucose | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [2-butenal co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein more ... | CTD | PMID:18948400 more ... |
Slc2a1 | Rat | glucose | increases transport | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein results in increased transport of Glucose | CTD | PMID:18455367 and PMID:8457197 |
Slc2a1 | Rat | glucose | increases stability | ISO | SLC2A1 (Homo sapiens) | 6480464 | Glucose results in increased stability of SLC2A1 protein | CTD | PMID:11420438 |
Slc2a1 | Rat | glycidyl methacrylate | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | glycidyl methacrylate results in increased expression of SLC2A1 protein | CTD | PMID:36641056 |
Slc2a1 | Rat | glycine | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Glycine results in decreased expression of SLC2A1 protein | CTD | PMID:30605748 |
Slc2a1 | Rat | glyphosate | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Glyphosate results in increased expression of SLC2A1 mRNA | CTD | PMID:36572786 |
Slc2a1 | Rat | glyphosate | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Glyphosate results in increased expression of SLC2A1 protein | CTD | PMID:30605748 |
Slc2a1 | Rat | hexadecanoic acid | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of SLC2A1 mRNA | CTD | PMID:30547786 |
Slc2a1 | Rat | hispidulin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | hispidulin inhibits the reaction [SLC2A1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1 and 3-diazol-4-yl)amino)-2-deoxyglucose] | CTD | PMID:36870413 |
Slc2a1 | Rat | hydrazine | increases expression | EXP | | 6480464 | hydrazine results in increased expression of SLC2A1 mRNA | CTD | PMID:15370871 |
Slc2a1 | Rat | hydrogen peroxide | affects expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of SLC2A1 mRNA | CTD | PMID:20044591 |
Slc2a1 | Rat | hydrogen peroxide | multiple interactions | EXP | | 6480464 | cordycepin inhibits the reaction [Hydrogen Peroxide results in decreased expression of SLC2A1 mRNA] and cordycepin inhibits the reaction [Hydrogen Peroxide results in decreased expression of SLC2A1 protein] | CTD | PMID:35196519 |
Slc2a1 | Rat | hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of SLC2A1 mRNA and Hydrogen Peroxide results in decreased expression of SLC2A1 protein | CTD | PMID:35196519 |
Slc2a1 | Rat | hydrogen peroxide | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in decreased expression of SLC2A1 protein | CTD | PMID:21179406 |
Slc2a1 | Rat | hydrogen sulfide | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Hydrogen Sulfide results in decreased expression of SLC2A1 protein | CTD | PMID:29932956 |
Slc2a1 | Rat | hydroquinone | increases expression | EXP | | 6480464 | hydroquinone results in increased expression of SLC2A1 protein | CTD | PMID:27587462 |
Slc2a1 | Rat | ibuprofen | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Ibuprofen results in decreased expression of SLC2A1 protein | CTD | PMID:12912967 |
Slc2a1 | Rat | ibuprofen | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Ibuprofen results in increased expression of SLC2A1 mRNA | CTD | PMID:25596134 |
Slc2a1 | Rat | Icaritin | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | icaritin results in decreased expression of SLC2A1 mRNA and icaritin results in decreased expression of SLC2A1 protein | CTD | PMID:38431053 |
Slc2a1 | Rat | Icaritin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [icaritin results in decreased expression of SLC2A1 protein] more ... | CTD | PMID:38431053 |
Slc2a1 | Rat | ifosfamide | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Ifosfamide results in increased expression of SLC2A1 mRNA | CTD | PMID:25596134 |
Slc2a1 | Rat | indometacin | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | Indomethacin inhibits the reaction [Nickel results in increased expression of SLC2A1 mRNA] | CTD | PMID:27452194 |
Slc2a1 | Rat | iron dichloride | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | ferrous chloride results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
Slc2a1 | Rat | isoliquiritigenin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | isoliquiritigenin inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
Slc2a1 | Rat | isoliquiritigenin | decreases activity | ISO | SLC2A1 (Homo sapiens) | 6480464 | isoliquiritigenin results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
Slc2a1 | Rat | isoprenaline | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Isoproterenol results in increased expression of SLC2A1 mRNA | CTD | PMID:20003209 |
Slc2a1 | Rat | ivermectin | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Ivermectin results in decreased expression of SLC2A1 mRNA | CTD | PMID:28942281 |
Slc2a1 | Rat | ivermectin | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of SLC2A1 protein | CTD | PMID:32959892 |
Slc2a1 | Rat | kaempferide | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | kaempferide results in decreased expression of SLC2A1 mRNA | CTD | PMID:21865046 |
Slc2a1 | Rat | kaempferol | decreases activity | ISO | SLC2A1 (Homo sapiens) | 6480464 | kaempferol results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
Slc2a1 | Rat | kaempferol | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | kaempferol results in decreased expression of SLC2A1 mRNA | CTD | PMID:25719685 |
Slc2a1 | Rat | kaempferol | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | kaempferol inhibits the reaction [SLC2A1 protein affects the transport of Glucose] more ... | CTD | PMID:14642735 and PMID:36870413 |
Slc2a1 | Rat | ketoconazole | increases expression | EXP | | 6480464 | Ketoconazole results in increased expression of SLC2A1 mRNA | CTD | PMID:37077353 |
Slc2a1 | Rat | L-ascorbic acid | increases expression | EXP | | 6480464 | Ascorbic Acid results in increased expression of SLC2A1 mRNA | CTD | PMID:15372504 |
Slc2a1 | Rat | L-ascorbic acid | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Ascorbic Acid results in decreased expression of SLC2A1 mRNA and Ascorbic Acid results in decreased expression of SLC2A1 protein | CTD | PMID:38160894 |
Slc2a1 | Rat | L-ascorbic acid | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [arsenic trichloride co-treated with Ascorbic Acid] results in decreased expression of SLC2A1 mRNA more ... | CTD | PMID:38160894 |
Slc2a1 | Rat | L-ascorbic acid | affects expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Ascorbic Acid affects the expression of SLC2A1 protein | CTD | PMID:38160894 |
Slc2a1 | Rat | L-cysteine | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | Cysteine inhibits the reaction [[cinnamaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein] | CTD | PMID:20955755 |
Slc2a1 | Rat | L-dehydroascorbic acid | decreases transport | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein mutant form results in decreased transport of Dehydroascorbic Acid | CTD | PMID:11603379 |
Slc2a1 | Rat | L-dehydroascorbic acid | affects transport | EXP | | 6480464 | SLC2A1 protein affects the transport of Dehydroascorbic Acid | CTD | PMID:15590689 |
Slc2a1 | Rat | L-dehydroascorbic acid | affects uptake | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 mRNA affects the uptake of Dehydroascorbic Acid | CTD | PMID:16142743 |
Slc2a1 | Rat | L-mimosine | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Mimosine results in increased expression of SLC2A1 mRNA | CTD | PMID:25469848 |
Slc2a1 | Rat | L-mimosine | increases expression | EXP | | 6480464 | Mimosine results in increased expression of SLC2A1 mRNA | CTD | PMID:25469848 |
Slc2a1 | Rat | lanthanum trichloride | decreases expression | EXP | | 6480464 | lanthanum chloride results in decreased expression of SLC2A1 mRNA and lanthanum chloride results in decreased expression of SLC2A1 protein | CTD | PMID:29264619 |
Slc2a1 | Rat | lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of SLC2A1 mRNA and lead acetate results in increased expression of SLC2A1 protein | CTD | PMID:30980912 |
Slc2a1 | Rat | lead diacetate | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein and [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein] | CTD | PMID:34508822 |
Slc2a1 | Rat | lead diacetate | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 mRNA more ... | CTD | PMID:31874198 |
Slc2a1 | Rat | lead(0) | decreases expression | EXP | | 6480464 | Lead results in decreased expression of SLC2A1 protein | CTD | PMID:22129743 |
Slc2a1 | Rat | lead(0) | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein and [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein] | CTD | PMID:34508822 |
Slc2a1 | Rat | lead(0) | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 mRNA more ... | CTD | PMID:31874198 |
Slc2a1 | Rat | lead(0) | multiple interactions | EXP | | 6480464 | Plant Extracts inhibits the reaction [Lead results in decreased expression of SLC2A1 protein] | CTD | PMID:22129743 |
Slc2a1 | Rat | leflunomide | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | leflunomide results in increased expression of SLC2A1 mRNA | CTD | PMID:28988120 |
Slc2a1 | Rat | lipopolysaccharide | affects expression | EXP | | 6480464 | Lipopolysaccharides affects the expression of SLC2A1 protein | CTD | PMID:16902764 |
Slc2a1 | Rat | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [Valproic Acid co-treated with Lipopolysaccharides] results in decreased expression of SLC2A1 protein and Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of SLC2A1 mRNA] | CTD | PMID:16415329 and PMID:16902764 |
Slc2a1 | Rat | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of SLC2A1 mRNA | CTD | PMID:16415329 |
Slc2a1 | Rat | lithocholic acid | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Lithocholic Acid results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
Slc2a1 | Rat | luteolin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Luteolin inhibits the reaction [SLC2A1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1 and 3-diazol-4-yl)amino)-2-deoxyglucose] | CTD | PMID:36870413 |
Slc2a1 | Rat | LY294002 | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltous chloride results in increased expression of SLC2A1 protein] more ... | CTD | PMID:19808899 and PMID:35122754 |
Slc2a1 | Rat | LY294002 | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of SLC2A1 protein | CTD | PMID:35122754 |
Slc2a1 | Rat | LY294002 | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol F results in increased expression of SLC2A1 mRNA] more ... | CTD | PMID:15956784 and PMID:34147605 |
Slc2a1 | Rat | mebendazole | affects binding | ISO | SLC2A1 (Homo sapiens) | 6480464 | Mebendazole binds to SLC2A1 protein | CTD | PMID:37473966 |
Slc2a1 | Rat | mebendazole | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Mebendazole results in decreased expression of SLC2A1 mRNA | CTD | PMID:37473966 |
Slc2a1 | Rat | menadione | affects expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of SLC2A1 mRNA | CTD | PMID:20044591 |
Slc2a1 | Rat | menadione | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Vitamin K 3 results in decreased expression of SLC2A1 mRNA | CTD | PMID:25270620 |
Slc2a1 | Rat | mercaptoethanol | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | Mercaptoethanol inhibits the reaction [[cinnamaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein] | CTD | PMID:20955755 |
Slc2a1 | Rat | methapyrilene | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Methapyrilene] results in increased expression of SLC2A1 protein | CTD | PMID:28903497 |
Slc2a1 | Rat | methapyrilene | affects expression | EXP | | 6480464 | Methapyrilene affects the expression of SLC2A1 mRNA | CTD | PMID:28903497 |
Slc2a1 | Rat | methyl methanesulfonate | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of SLC2A1 mRNA | CTD | PMID:23649840 |
Slc2a1 | Rat | methylarsonic acid | increases import | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein results in increased import of monomethylarsonic acid | CTD | PMID:17064664 |
Slc2a1 | Rat | methylarsonic acid | increases import | EXP | | 6480464 | SLC2A1 protein results in increased import of monomethylarsonic acid | CTD | PMID:17064664 |
Slc2a1 | Rat | methylene blue | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | oxophenylarsine inhibits the reaction [Methylene Blue results in increased activity of SLC2A1 protein] | CTD | PMID:19686715 |
Slc2a1 | Rat | methylene blue | increases activity | ISO | Slc2a1 (Mus musculus) | 6480464 | Methylene Blue results in increased activity of SLC2A1 protein | CTD | PMID:19686715 |
Slc2a1 | Rat | methylmercury chloride | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | methylmercuric chloride results in increased expression of SLC2A1 protein | CTD | PMID:15649634 |
Slc2a1 | Rat | methylmercury chloride | multiple interactions | EXP | | 6480464 | 2-Methoxyestradiol promotes the reaction [methylmercuric chloride results in decreased expression of SLC2A1 protein] more ... | CTD | PMID:31850806 |
Slc2a1 | Rat | methylmercury chloride | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of SLC2A1 mRNA | CTD | PMID:23179753 and PMID:27188386 |
Slc2a1 | Rat | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of SLC2A1 protein | CTD | PMID:31850806 |
Slc2a1 | Rat | Mezerein | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | mezerein results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
Slc2a1 | Rat | mifepristone | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | Mifepristone inhibits the reaction [Progesterone results in increased expression of SLC2A1 protein] | CTD | PMID:18948400 |
Slc2a1 | Rat | minocycline | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Minocycline inhibits the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA] | CTD | PMID:24292262 |
Slc2a1 | Rat | mono(2-ethylhexyl) phthalate | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of SLC2A1 mRNA | CTD | PMID:31009676 |
Slc2a1 | Rat | mono(2-ethylhexyl) phthalate | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of SLC2A1 protein | CTD | PMID:38048874 |
Slc2a1 | Rat | Monobutylphthalate | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | monobutyl phthalate results in increased expression of SLC2A1 protein | CTD | PMID:38048874 |
Slc2a1 | Rat | Monobutylphthalate | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | monobutyl phthalate results in increased expression of SLC2A1 protein | CTD | PMID:36736749 |
Slc2a1 | Rat | monosodium L-glutamate | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [Rosiglitazone co-treated with Sodium Glutamate] results in decreased expression of SLC2A1 mRNA and [Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of SLC2A1 mRNA | CTD | PMID:18048028 and PMID:19001666 |
Slc2a1 | Rat | myricetin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Deferoxamine inhibits the reaction [myricetin inhibits the reaction [Formaldehyde results in increased expression of SLC2A1 mRNA]] more ... | CTD | PMID:14642735 and PMID:36116563 |
Slc2a1 | Rat | myricetin | decreases activity | ISO | SLC2A1 (Homo sapiens) | 6480464 | myricetin results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
Slc2a1 | Rat | N(4)-hydroxycytidine | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | N(4)-hydroxycytidine results in decreased expression of SLC2A1 mRNA | CTD | PMID:37748715 |
Slc2a1 | Rat | N-acetyl-L-cysteine | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [2 more ... | CTD | PMID:30821169 more ... |
Slc2a1 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SLC2A1 protein | CTD | PMID:17442736 |
Slc2a1 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [methylmercuric chloride results in decreased expression of SLC2A1 protein] and benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Methylmercury Compounds results in decreased expression of SLC2A1 protein] | CTD | PMID:31850806 and PMID:32461003 |
Slc2a1 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SLC2A1 protein | CTD | PMID:31850806 and PMID:32461003 |
Slc2a1 | Rat | N-methyl-4-phenylpyridinium | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of SLC2A1 mRNA | CTD | PMID:17475336 |
Slc2a1 | Rat | N-methyl-4-phenylpyridinium | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium promotes the reaction [IL4 protein results in increased expression of SLC2A1 mRNA] and IL4 protein promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SLC2A1 mRNA] | CTD | PMID:32606391 |
Slc2a1 | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of SLC2A1 mRNA | CTD | PMID:30686998 and PMID:32606391 |
Slc2a1 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC2A1 protein more ... | CTD | PMID:28903497 |
Slc2a1 | Rat | N-nitrosomorpholine | increases expression | EXP | | 6480464 | N-nitrosomorpholine results in increased expression of SLC2A1 protein | CTD | PMID:7921415 and PMID:8364915 |
Slc2a1 | Rat | N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine | multiple interactions | EXP | | 6480464 | Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of SLC2A1 mRNA] | CTD | PMID:16415329 |
Slc2a1 | Rat | nickel atom | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Nickel results in increased expression of SLC2A1 mRNA | CTD | PMID:24768652 and PMID:25583101 |
Slc2a1 | Rat | nickel atom | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Nickel results in increased expression of SLC2A1 mRNA | CTD | PMID:27452194 |
Slc2a1 | Rat | nickel atom | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | Celecoxib inhibits the reaction [Nickel results in increased expression of SLC2A1 mRNA] more ... | CTD | PMID:27452194 |
Slc2a1 | Rat | nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:22110744 |
Slc2a1 | Rat | nickel dichloride | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | nickel chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:12426141 more ... |
Slc2a1 | Rat | nickel dichloride | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | Dinoprostone promotes the reaction [nickel chloride results in increased expression of SLC2A1 mRNA] and HIF1A affects the reaction [nickel chloride results in increased expression of SLC2A1 mRNA] | CTD | PMID:12426141 more ... |
Slc2a1 | Rat | nickel dichloride | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | nickel chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:33596451 |
Slc2a1 | Rat | nickel dichloride | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | 2-amino-3-(4'-N and N-bis(2-chloroethyl)amino)phenylpropionic acid N-oxide inhibits the reaction [nickel chloride results in increased expression of SLC2A1 mRNA] | CTD | PMID:33596451 |
Slc2a1 | Rat | nickel subsulfide | affects expression | ISO | Slc2a1 (Mus musculus) | 6480464 | nickel subsulfide affects the expression of SLC2A1 mRNA | CTD | PMID:12729255 |
Slc2a1 | Rat | nickel sulfate | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | nickel sulfate results in increased expression of SLC2A1 mRNA | CTD | PMID:16100012 |
Slc2a1 | Rat | niclosamide | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Niclosamide results in decreased expression of SLC2A1 mRNA | CTD | PMID:22576131 |
Slc2a1 | Rat | Niflumic acid | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | SLC2A1 inhibits the reaction [Niflumic Acid results in increased uptake of Hexoses] | CTD | PMID:16447059 |
Slc2a1 | Rat | nimesulide | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | SLC2A1 inhibits the reaction [nimesulide results in increased uptake of Hexoses] | CTD | PMID:16447059 |
Slc2a1 | Rat | nobiletin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | nobiletin inhibits the reaction [SLC2A1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1 and 3-diazol-4-yl)amino)-2-deoxyglucose] | CTD | PMID:36870413 |
Slc2a1 | Rat | Nonidet P-40 | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Nonidet P-40 results in increased expression of SLC2A1 mRNA | CTD | PMID:26552463 |
Slc2a1 | Rat | ochratoxin A | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | ochratoxin A results in increased expression of SLC2A1 mRNA and ochratoxin A results in increased expression of SLC2A1 protein | CTD | PMID:32835834 |
Slc2a1 | Rat | ofloxacin | affects localization | ISO | SLC2A1 (Homo sapiens) | 6480464 | Ofloxacin affects the localization of SLC2A1 mRNA | CTD | PMID:19022360 |
Slc2a1 | Rat | ofloxacin | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Ofloxacin results in decreased expression of SLC2A1 mRNA | CTD | PMID:19022360 |
Slc2a1 | Rat | okadaic acid | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Okadaic Acid results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
Slc2a1 | Rat | okadaic acid | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of SLC2A1 mRNA | CTD | PMID:28939011 |
Slc2a1 | Rat | oleic acid | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of SLC2A1 mRNA | CTD | PMID:30547786 |
Slc2a1 | Rat | organoselenium compound | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Organoselenium Compounds binds to Copper] which results in increased expression of SLC2A1 mRNA | CTD | PMID:25167922 |
Slc2a1 | Rat | ozone | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Ozone results in increased expression of SLC2A1 mRNA | CTD | PMID:27206323 |
Slc2a1 | Rat | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of SLC2A1 mRNA | CTD | PMID:37088303 |
Slc2a1 | Rat | p-chloromercuribenzoic acid | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of SLC2A1 mRNA | CTD | PMID:26272509 |
Slc2a1 | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC2A1 mRNA | CTD | PMID:27188386 |
Slc2a1 | Rat | palytoxin | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | palytoxin results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
Slc2a1 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SLC2A1 mRNA | CTD | PMID:17522070 and PMID:33387578 |
Slc2a1 | Rat | paracetamol | affects expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SLC2A1 mRNA | CTD | PMID:17562736 |
Slc2a1 | Rat | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of SLC2A1 mRNA | CTD | PMID:18198484 and PMID:32680482 |
Slc2a1 | Rat | paraquat | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Paraquat results in increased expression of SLC2A1 mRNA | CTD | PMID:21463325 |
Slc2a1 | Rat | pentachlorophenol | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of SLC2A1 mRNA | CTD | PMID:23892564 |
Slc2a1 | Rat | pentobarbital | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Pentobarbital inhibits the reaction [SLC2A1 protein results in increased uptake of 3-O-Methylglucose] and Pentobarbital promotes the reaction [SLC2A1 gene polymorphism results in decreased uptake of 3-O-Methylglucose] | CTD | PMID:10590023 |
Slc2a1 | Rat | pentobarbital | decreases activity | ISO | SLC2A1 (Homo sapiens) | 6480464 | Pentobarbital results in decreased activity of SLC2A1 protein | CTD | PMID:10590023 |
Slc2a1 | Rat | perfluorononanoic acid | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in increased expression of SLC2A1 mRNA | CTD | PMID:38568856 |
Slc2a1 | Rat | perfluorooctane-1-sulfonic acid | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of SLC2A1 mRNA | CTD | PMID:32790152 |
Slc2a1 | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in increased expression of SLC2A1 mRNA | CTD | PMID:36674557 |
Slc2a1 | Rat | perfluorooctanoic acid | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of SLC2A1 mRNA | CTD | PMID:32790152 and PMID:36326898 |
Slc2a1 | Rat | permethrin | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA more ... | CTD | PMID:29751049 |
Slc2a1 | Rat | phenobarbital | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Phenobarbital inhibits the reaction [SLC2A1 protein results in increased uptake of 3-O-Methylglucose] and Phenobarbital promotes the reaction [SLC2A1 gene polymorphism results in decreased uptake of 3-O-Methylglucose] | CTD | PMID:10590023 |
Slc2a1 | Rat | phenobarbital | affects expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Phenobarbital affects the expression of SLC2A1 mRNA | CTD | PMID:23091169 |
Slc2a1 | Rat | phenobarbital | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
Slc2a1 | Rat | phenobarbital | affects expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of SLC2A1 mRNA | CTD | PMID:19159669 |
Slc2a1 | Rat | phenobarbital | decreases activity | ISO | SLC2A1 (Homo sapiens) | 6480464 | Phenobarbital results in decreased activity of SLC2A1 protein | CTD | PMID:10590023 |
Slc2a1 | Rat | phenylarsine oxide | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | oxophenylarsine inhibits the reaction [Cytochalasin B binds to SLC2A1 protein] more ... | CTD | PMID:19686715 |
Slc2a1 | Rat | phenylarsine oxide | affects activity | ISO | Slc2a1 (Mus musculus) | 6480464 | oxophenylarsine affects the activity of SLC2A1 protein | CTD | PMID:19686715 |
Slc2a1 | Rat | phenylephrine | increases expression | EXP | | 6480464 | Phenylephrine results in increased expression of SLC2A1 mRNA | CTD | PMID:15808844 |
Slc2a1 | Rat | phenylmercury acetate | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of SLC2A1 mRNA | CTD | PMID:26272509 |
Slc2a1 | Rat | phenylmercury acetate | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A1 mRNA | CTD | PMID:27188386 |
Slc2a1 | Rat | phloretin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Phloretin inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
Slc2a1 | Rat | phloretin | decreases activity | ISO | SLC2A1 (Homo sapiens) | 6480464 | Phloretin results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
Slc2a1 | Rat | phorbol 13-acetate 12-myristate | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
Slc2a1 | Rat | pifithrin-alpha hydrobromide | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | pifithrin inhibits the reaction [icaritin results in decreased expression of SLC2A1 mRNA] and pifithrin inhibits the reaction [icaritin results in decreased expression of SLC2A1 protein] | CTD | PMID:38431053 |
Slc2a1 | Rat | pifithrin-alpha hydrobromide | multiple interactions | EXP | | 6480464 | pifithrin inhibits the reaction [triptolide results in decreased expression of SLC2A1 protein] | CTD | PMID:31618665 |
Slc2a1 | Rat | piperonyl butoxide | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of SLC2A1 protein | CTD | PMID:28903497 |
Slc2a1 | Rat | pirinixic acid | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of SLC2A1 mRNA | CTD | PMID:17426115 |
Slc2a1 | Rat | potassium chromate | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of SLC2A1 mRNA | CTD | PMID:22079256 |
Slc2a1 | Rat | potassium chromate | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC2A1 mRNA | CTD | PMID:22079256 |
Slc2a1 | Rat | potassium dichromate | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | 3-methyladenine inhibits the reaction [Potassium Dichromate results in increased expression of SLC2A1 protein] more ... | CTD | PMID:32569804 and PMID:36473502 |
Slc2a1 | Rat | potassium dichromate | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Potassium Dichromate results in increased expression of SLC2A1 protein | CTD | PMID:32569804 and PMID:36473502 |
Slc2a1 | Rat | probenecid | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:25064079 |
Slc2a1 | Rat | prochloraz | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | prochloraz results in decreased expression of SLC2A1 mRNA | CTD | PMID:30879083 |
Slc2a1 | Rat | progesterone | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Progesterone results in increased expression of SLC2A1 protein | CTD | PMID:15350188 |
Slc2a1 | Rat | progesterone | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Progesterone results in increased expression of SLC2A1 mRNA | CTD | PMID:18948400 |
Slc2a1 | Rat | progesterone | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [Progesterone results in increased expression of SLC2A1 protein] which results in increased uptake of Glucose more ... | CTD | PMID:18948400 |
Slc2a1 | Rat | progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of SLC2A1 mRNA | CTD | PMID:20726854 |
Slc2a1 | Rat | progesterone | multiple interactions | EXP | | 6480464 | Progesterone promotes the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA] | CTD | PMID:23307114 |
Slc2a1 | Rat | progesterone | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Progesterone co-treated with Bucladesine] results in increased expression of SLC2A1 protein and [Progesterone co-treated with Estradiol] results in decreased expression of SLC2A1 protein | CTD | PMID:15350188 and PMID:18948400 |
Slc2a1 | Rat | promethazine | decreases expression | EXP | | 6480464 | Promethazine results in decreased expression of SLC2A1 mRNA | CTD | PMID:28903497 |
Slc2a1 | Rat | propanal | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [propionaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein | CTD | PMID:20955755 |
Slc2a1 | Rat | propanal | increases activity | ISO | Slc2a1 (Mus musculus) | 6480464 | propionaldehyde results in increased activity of SLC2A1 protein | CTD | PMID:20955755 |
Slc2a1 | Rat | propofol | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Propofol results in decreased expression of SLC2A1 protein | CTD | PMID:36207479 |
Slc2a1 | Rat | prostaglandin E2 | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | Dinoprostone promotes the reaction [nickel chloride results in increased expression of SLC2A1 mRNA] | CTD | PMID:27452194 |
Slc2a1 | Rat | prostaglandin E2 | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Dinoprostone results in increased expression of SLC2A1 mRNA | CTD | PMID:27452194 |
Slc2a1 | Rat | protoporphyrin | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | protoporphyrin IX results in decreased expression of SLC2A1 mRNA | CTD | PMID:23624237 |
Slc2a1 | Rat | puerarin | multiple interactions | EXP | | 6480464 | puerarin inhibits the reaction [[cadmium acetate results in increased abundance of Cadmium] which results in decreased expression of SLC2A1 protein] | CTD | PMID:33404196 |
Slc2a1 | Rat | Pyridostigmine bromide | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA more ... | CTD | PMID:29751049 |
Slc2a1 | Rat | pyrithiamine | decreases expression | EXP | | 6480464 | Pyrithiamine results in decreased expression of SLC2A1 protein | CTD | PMID:27984051 |
Slc2a1 | Rat | quercetin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Quercetin inhibits the reaction [SLC2A1 protein affects the transport of Glucose] more ... | CTD | PMID:14642735 and PMID:36870413 |
Slc2a1 | Rat | quercetin | affects localization | ISO | SLC2A1 (Homo sapiens) | 6480464 | Quercetin affects the localization of SLC2A1 protein | CTD | PMID:26943884 |
Slc2a1 | Rat | quercetin | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of SLC2A1 mRNA | CTD | PMID:20596804 |
Slc2a1 | Rat | quercetin | decreases activity | ISO | SLC2A1 (Homo sapiens) | 6480464 | Quercetin results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
Slc2a1 | Rat | ranitidine | multiple interactions | EXP | | 6480464 | Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of SLC2A1 mRNA] | CTD | PMID:16415329 |
Slc2a1 | Rat | resveratrol | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | resveratrol results in decreased expression of SLC2A1 protein | CTD | PMID:24221993 |
Slc2a1 | Rat | resveratrol | affects binding | ISO | SLC2A1 (Homo sapiens) | 6480464 | resveratrol binds to SLC2A1 protein | CTD | PMID:23615963 |
Slc2a1 | Rat | resveratrol | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [resveratrol binds to SLC2A1 protein] which results in decreased transport of Hexoses and resveratrol inhibits the reaction [SLC2A1 protein results in increased uptake of Glucose] | CTD | PMID:23615963 |
Slc2a1 | Rat | rofecoxib | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | SLC2A1 inhibits the reaction [rofecoxib results in increased uptake of Hexoses] | CTD | PMID:16447059 |
Slc2a1 | Rat | rotenone | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA] and SLC2A1 protein inhibits the reaction [Rotenone results in increased activity of MAPK8 protein] | CTD | PMID:10780954 and PMID:19091749 |
Slc2a1 | Rat | rotenone | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of SLC2A1 mRNA | CTD | PMID:36586010 |
Slc2a1 | Rat | rotenone | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Rotenone results in increased expression of SLC2A1 mRNA | CTD | PMID:30686998 |
Slc2a1 | Rat | rotenone | decreases response to substance | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein results in decreased susceptibility to Rotenone | CTD | PMID:10780954 |
Slc2a1 | Rat | roxadustat | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | roxadustat results in increased expression of SLC2A1 mRNA | CTD | PMID:33596451 |
Slc2a1 | Rat | saccharin | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Saccharin results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
Slc2a1 | Rat | sarpogrelate | affects expression | EXP | | 6480464 | sarpogrelate affects the expression of SLC2A1 protein | CTD | PMID:21183729 |
Slc2a1 | Rat | SB 431542 | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:37664457 |
Slc2a1 | Rat | serpentine asbestos | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Asbestos and Serpentine results in increased expression of SLC2A1 mRNA | CTD | PMID:29523930 |
Slc2a1 | Rat | sevoflurane | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Sevoflurane results in increased expression of SLC2A1 protein | CTD | PMID:36207479 |
Slc2a1 | Rat | sevoflurane | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Sevoflurane results in decreased expression of SLC2A1 protein | CTD | PMID:35249202 |
Slc2a1 | Rat | sildenafil citrate | multiple interactions | EXP | | 6480464 | Sildenafil Citrate inhibits the reaction [Aflatoxin B1 results in increased expression of SLC2A1 mRNA] | CTD | PMID:35608386 |
Slc2a1 | Rat | silibinin | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Silybin results in decreased expression of SLC2A1 protein | CTD | PMID:34053323 |
Slc2a1 | Rat | silibinin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | 3-methyladenine promotes the reaction [Silybin results in decreased expression of SLC2A1 protein] and dorsomorphin promotes the reaction [Silybin results in decreased expression of SLC2A1 protein] | CTD | PMID:34053323 |
Slc2a1 | Rat | sinensetin | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | sinensetin inhibits the reaction [SLC2A1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1 and 3-diazol-4-yl)amino)-2-deoxyglucose] | CTD | PMID:36870413 |
Slc2a1 | Rat | sirolimus | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Sirolimus inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A1 protein] and Sirolimus inhibits the reaction [ATG4B protein results in increased expression of SLC2A1 protein] | CTD | PMID:36336208 |
Slc2a1 | Rat | sodium arsenite | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of SLC2A1 mRNA | CTD | PMID:12760830 and PMID:36586010 |
Slc2a1 | Rat | sodium arsenite | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [[Deoxyglucose results in increased abundance of Glucose] which affects the localization of SLC2A1 protein] | CTD | PMID:31398423 |
Slc2a1 | Rat | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of SLC2A1 protein | CTD | PMID:29459688 |
Slc2a1 | Rat | sodium arsenite | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of SLC2A1 mRNA and sodium arsenite results in decreased expression of SLC2A1 protein | CTD | PMID:25576766 more ... |
Slc2a1 | Rat | sodium arsenite | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of SLC2A1 mRNA | CTD | PMID:20886546 |
Slc2a1 | Rat | sodium azide | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Sodium Azide results in increased expression of SLC2A1 mRNA | CTD | PMID:14578187 |
Slc2a1 | Rat | sodium chloride | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Sodium Chloride results in increased expression of SLC2A1 protein | CTD | PMID:20025956 |
Slc2a1 | Rat | sodium chloride | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of SLC2A1 protein more ... | CTD | PMID:38598786 |
Slc2a1 | Rat | sodium chloride | multiple interactions | EXP | | 6480464 | [Desoxycorticosterone Acetate co-treated with Sodium Chloride co-treated with cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester] results in increased expression of SLC2A1 protein | CTD | PMID:29621749 |
Slc2a1 | Rat | sodium dichromate | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | sodium bichromate results in decreased expression of SLC2A1 mRNA | CTD | PMID:12760830 |
Slc2a1 | Rat | streptozocin | multiple interactions | EXP | | 6480464 | [Streptozocin co-treated with Dietary Fats] results in decreased expression of SLC2A1 protein more ... | CTD | PMID:16409969 and PMID:35151640 |
Slc2a1 | Rat | streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of SLC2A1 mRNA | CTD | PMID:16409969 |
Slc2a1 | Rat | sulfadimethoxine | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Sulfadimethoxine results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
Slc2a1 | Rat | sunitinib | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of SLC2A1 mRNA | CTD | PMID:31533062 |
Slc2a1 | Rat | tadalafil | multiple interactions | EXP | | 6480464 | Tadalafil inhibits the reaction [Aflatoxin B1 results in increased expression of SLC2A1 mRNA] | CTD | PMID:35608386 |
Slc2a1 | Rat | tamoxifen | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | Tamoxifen inhibits the reaction [SLC2A1 protein affects the transport of Glucose] | CTD | PMID:14642735 |
Slc2a1 | Rat | tamoxifen | affects expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Tamoxifen affects the expression of SLC2A1 mRNA | CTD | PMID:17555576 |
Slc2a1 | Rat | tamoxifen | decreases activity | ISO | SLC2A1 (Homo sapiens) | 6480464 | Tamoxifen results in decreased activity of SLC2A1 protein | CTD | PMID:14642735 |
Slc2a1 | Rat | temozolomide | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of SLC2A1 mRNA | CTD | PMID:31758290 |
Slc2a1 | Rat | tetrachloromethane | affects expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of SLC2A1 mRNA | CTD | PMID:17484886 |
Slc2a1 | Rat | tetrachloromethane | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of SLC2A1 mRNA | CTD | PMID:27339419 and PMID:31919559 |
Slc2a1 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of SLC2A1 mRNA | CTD | PMID:17522070 |
Slc2a1 | Rat | tetracycline | increases expression | EXP | | 6480464 | Tetracycline results in increased expression of SLC2A1 mRNA | CTD | PMID:17522070 |
Slc2a1 | Rat | tetraethylenepentamine | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | tetraethylenepentamine inhibits the reaction [cobaltous chloride results in increased expression of SLC2A1 mRNA] | CTD | PMID:25100165 |
Slc2a1 | Rat | tetrathiomolybdate(2-) | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | tetrathiomolybdate results in decreased expression of SLC2A1 mRNA | CTD | PMID:37290678 |
Slc2a1 | Rat | thimerosal | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of SLC2A1 mRNA | CTD | PMID:27188386 |
Slc2a1 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of SLC2A1 mRNA | CTD | PMID:28903497 |
Slc2a1 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of SLC2A1 mRNA | CTD | PMID:34492290 |
Slc2a1 | Rat | thioacetamide | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of SLC2A1 protein | CTD | PMID:28903497 |
Slc2a1 | Rat | tin(II) chloride (anhydrous) | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | stannous chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 |
Slc2a1 | Rat | titanium dioxide | decreases methylation | ISO | Slc2a1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of SLC2A1 gene | CTD | PMID:35295148 |
Slc2a1 | Rat | tolbutamide | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Tolbutamide results in increased expression of SLC2A1 mRNA and Tolbutamide results in increased expression of SLC2A1 protein | CTD | PMID:11835228 and PMID:2682625 |
Slc2a1 | Rat | tolfenamic acid | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | tolfenamic acid affects the reaction [TGFB1 protein affects the expression of SLC2A1 protein] | CTD | PMID:31381904 |
Slc2a1 | Rat | toluene | increases expression | EXP | | 6480464 | Toluene results in increased expression of SLC2A1 mRNA | CTD | PMID:22967744 |
Slc2a1 | Rat | Tributyltin oxide | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of SLC2A1 mRNA | CTD | PMID:25270620 |
Slc2a1 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of SLC2A1 mRNA | CTD | PMID:33387578 |
Slc2a1 | Rat | trichostatin A | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of SLC2A1 mRNA | CTD | PMID:24935251 |
Slc2a1 | Rat | triclosan | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Triclosan results in increased expression of SLC2A1 mRNA | CTD | PMID:30510588 and PMID:38048832 |
Slc2a1 | Rat | Triptolide | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | triptolide results in decreased expression of SLC2A1 mRNA and triptolide results in decreased expression of SLC2A1 protein | CTD | PMID:31618665 and PMID:34087332 |
Slc2a1 | Rat | Triptolide | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | triptolide results in increased expression of SLC2A1 mRNA | CTD | PMID:34087332 |
Slc2a1 | Rat | Triptolide | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | TRP53 protein affects the reaction [triptolide results in decreased expression of SLC2A1 protein] | CTD | PMID:31618665 |
Slc2a1 | Rat | Triptolide | multiple interactions | EXP | | 6480464 | pifithrin inhibits the reaction [triptolide results in decreased expression of SLC2A1 protein] | CTD | PMID:31618665 |
Slc2a1 | Rat | Triptolide | decreases expression | EXP | | 6480464 | triptolide results in decreased expression of SLC2A1 protein | CTD | PMID:31618665 |
Slc2a1 | Rat | triptonide | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | triptonide results in decreased expression of SLC2A1 mRNA | CTD | PMID:33045310 |
Slc2a1 | Rat | tris(2-butoxyethyl) phosphate | affects expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of SLC2A1 mRNA | CTD | PMID:29024780 |
Slc2a1 | Rat | troglitazone | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | troglitazone results in increased expression of SLC2A1 mRNA and troglitazone results in increased expression of SLC2A1 protein | CTD | PMID:9544743 and PMID:9589670 |
Slc2a1 | Rat | troglitazone | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | troglitazone results in decreased expression of SLC2A1 mRNA | CTD | PMID:11162573 |
Slc2a1 | Rat | troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of SLC2A1 mRNA | CTD | PMID:10726906 |
Slc2a1 | Rat | troglitazone | multiple interactions | EXP | | 6480464 | [troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose | CTD | PMID:10726906 |
Slc2a1 | Rat | troglitazone | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | troglitazone results in increased expression of SLC2A1 mRNA and troglitazone results in increased expression of SLC2A1 protein | CTD | PMID:28973697 and PMID:8895337 |
Slc2a1 | Rat | troglitazone | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose and [troglitazone results in increased expression of SLC2A1 protein] which results in increased uptake of Glucose | CTD | PMID:8895337 |
Slc2a1 | Rat | tunicamycin | decreases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | Tunicamycin results in decreased expression of SLC2A1 mRNA | CTD | PMID:24370435 |
Slc2a1 | Rat | tunicamycin | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of SLC2A1 protein | CTD | PMID:36473502 |
Slc2a1 | Rat | tunicamycin | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Tunicamycin results in decreased expression of SLC2A1 mRNA | CTD | PMID:22378314 |
Slc2a1 | Rat | ubiquinone-0 | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | ubiquinone-O results in decreased expression of SLC2A1 mRNA and ubiquinone-O results in decreased expression of SLC2A1 protein | CTD | PMID:36847822 |
Slc2a1 | Rat | valproic acid | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | cobaltous chloride inhibits the reaction [Valproic Acid inhibits the reaction [Colforsin results in increased expression of SLC2A1 protein]] more ... | CTD | PMID:18455367 and PMID:38296531 |
Slc2a1 | Rat | valproic acid | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SLC2A1 mRNA | CTD | PMID:23179753 and PMID:27188386 |
Slc2a1 | Rat | valproic acid | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SLC2A1 mRNA | CTD | PMID:23179753 more ... |
Slc2a1 | Rat | valproic acid | multiple interactions | EXP | | 6480464 | [Valproic Acid co-treated with Lipopolysaccharides] results in decreased expression of SLC2A1 protein | CTD | PMID:16902764 |
Slc2a1 | Rat | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of SLC2A1 protein | CTD | PMID:16902764 |
Slc2a1 | Rat | vanadium atom | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Vanadium results in increased expression of SLC2A1 protein | CTD | PMID:26039747 |
Slc2a1 | Rat | vanadium(0) | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Vanadium results in increased expression of SLC2A1 protein | CTD | PMID:26039747 |
Slc2a1 | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of SLC2A1 mRNA | CTD | PMID:23034163 |
Slc2a1 | Rat | vincristine | decreases response to substance | ISO | SLC2A1 (Homo sapiens) | 6480464 | SLC2A1 protein results in decreased susceptibility to Vincristine | CTD | PMID:17520257 |
Slc2a1 | Rat | vorinostat | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of SLC2A1 mRNA | CTD | PMID:27188386 |
Slc2a1 | Rat | Yessotoxin | increases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | yessotoxin analog results in increased expression of SLC2A1 mRNA | CTD | PMID:30679557 |
Slc2a1 | Rat | zidovudine | decreases expression | ISO | SLC2A1 (Homo sapiens) | 6480464 | Zidovudine results in decreased expression of SLC2A1 mRNA | CTD | PMID:24292225 |
Slc2a1 | Rat | zinc acetate | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein] | CTD | PMID:34508822 |
Slc2a1 | Rat | zinc atom | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein] | CTD | PMID:34508822 |
Slc2a1 | Rat | zinc dichloride | multiple interactions | ISO | SLC2A1 (Homo sapiens) | 6480464 | zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of SLC2A1 mRNA] | CTD | PMID:22202117 |
Slc2a1 | Rat | zinc dichloride | increases expression | ISO | Slc2a1 (Mus musculus) | 6480464 | zinc chloride results in increased expression of SLC2A1 mRNA | CTD | PMID:19000923 and PMID:37797845 |
Slc2a1 | Rat | zinc(0) | multiple interactions | ISO | Slc2a1 (Mus musculus) | 6480464 | [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein] | CTD | PMID:34508822 |